Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer.

Chung Ryul OhEo Jin KimHeejung ChaeYoung Soo ParkMin-Hee RyuHyung-Don KimYoon-Koo Kang

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)

Efficacy of first-line FP was not different by MMR status in mGC patients.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
squamous cell carcinoma
small cell lung cancer
peritoneal dialysis
prognostic factors